Encephalomyelitis, Acute Disseminated
"Encephalomyelitis, Acute Disseminated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An acute or subacute inflammatory process of the CENTRAL NERVOUS SYSTEM characterized histologically by multiple foci of perivascular demyelination. Symptom onset usually occurs several days after an acute viral infection or immunization, but it may coincide with the onset of infection or rarely no antecedent event can be identified. Clinical manifestations include CONFUSION, somnolence, FEVER, nuchal rigidity, and involuntary movements. The illness may progress to COMA and eventually be fatal. (Adams et al., Principles of Neurology, 6th ed, p921)
MeSH Number(s)
C10.114.375.225
C10.228.140.695.562.225
C10.228.518.562.225
C10.314.350.225
C20.111.258.250.350
Concept/Terms
Encephalomyelitis, Acute Disseminated- Encephalomyelitis, Acute Disseminated
- Disseminated Encephalomyelitis, Acute
- Acute Disseminated Encephalomyelitis
- Acute Disseminated Encephalomyelitides
- Disseminated Encephalomyelitides, Acute
- Encephalomyelitides, Acute Disseminated
Encephalitis, Post-Vaccinal- Encephalitis, Post-Vaccinal
- Encephalitis, Post Vaccinal
- Post-Vaccinal Encephalomyelitis
- Encephalomyelitides, Post-Vaccinal
- Encephalomyelitis, Post-Vaccinal
- Post Vaccinal Encephalomyelitis
- Post-Vaccinal Encephalomyelitides
- Post-Vaccinal Encephalitis
- Encephalitides, Post-Vaccinal
- Post Vaccinal Encephalitis
- Post-Vaccinal Encephalitides
- Encephalitis, Postvaccinal
- Encephalitis, Vaccination
- Vaccination Encephalitis
- Postvaccinal Encephalitis
Below are MeSH descriptors whose meaning is more general than "Encephalomyelitis, Acute Disseminated".
- Diseases [C]
- Nervous System Diseases [C10]
- Autoimmune Diseases of the Nervous System [C10.114]
- Demyelinating Autoimmune Diseases, CNS [C10.114.375]
- Encephalomyelitis, Acute Disseminated [C10.114.375.225]
- Central Nervous System Diseases [C10.228]
- Brain Diseases [C10.228.140]
- Leukoencephalopathies [C10.228.140.695]
- Demyelinating Autoimmune Diseases, CNS [C10.228.140.695.562]
- Encephalomyelitis, Acute Disseminated [C10.228.140.695.562.225]
- Leukoencephalopathies [C10.228.518]
- Demyelinating Autoimmune Diseases, CNS [C10.228.518.562]
- Encephalomyelitis, Acute Disseminated [C10.228.518.562.225]
- Demyelinating Diseases [C10.314]
- Demyelinating Autoimmune Diseases, CNS [C10.314.350]
- Encephalomyelitis, Acute Disseminated [C10.314.350.225]
- Immune System Diseases [C20]
- Autoimmune Diseases [C20.111]
- Autoimmune Diseases of the Nervous System [C20.111.258]
- Demyelinating Autoimmune Diseases, CNS [C20.111.258.250]
- Encephalomyelitis, Acute Disseminated [C20.111.258.250.350]
Below are MeSH descriptors whose meaning is more specific than "Encephalomyelitis, Acute Disseminated".
This graph shows the total number of publications written about "Encephalomyelitis, Acute Disseminated" by people in Harvard Catalyst Profiles by year, and whether "Encephalomyelitis, Acute Disseminated" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 0 | 1 |
| 2013 | 3 | 1 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 2 | 4 |
| 2016 | 3 | 0 | 3 |
| 2017 | 1 | 0 | 1 |
| 2019 | 4 | 0 | 4 |
| 2020 | 2 | 0 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 1 | 0 | 1 |
Below are the most recent publications written about "Encephalomyelitis, Acute Disseminated" by people in Profiles.
-
Therapeutic plasma exchange in pediatric patients with acute demyelinating syndromes of the central nervous system: A single-center experience. Transfus Apher Sci. 2022 Aug; 61(4):103421.
-
COVID-19-associated Acute Disseminated Encephalomyelitis-like Disease in 2 Children. Pediatr Infect Dis J. 2021 11 01; 40(11):e445-e450.
-
Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. Mult Scler Relat Disord. 2021 Nov; 56:103229.
-
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19: Systematic Review and Meta-synthesis. Neurol Neuroimmunol Neuroinflamm. 2021 11; 8(6).
-
Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases. J Neuroimmunol. 2021 10 15; 359:577674.
-
Magnetic resonance imaging at baseline and follow-up to differentiate between pediatric monophasic acquired CNS demyelination and MS. Mult Scler Relat Disord. 2020 Nov; 46:102590.
-
Variation in Treatment and Outcomes of Children With Acute Disseminated Encephalomyelitis. Hosp Pediatr. 2020 02; 10(2):159-165.
-
Whole exome sequencing in a child with acute disseminated encephalomyelitis, optic neuritis, and periodic fever syndrome: a case report. J Med Case Rep. 2019 Dec 14; 13(1):368.
-
School performance and psychiatric morbidity 6 years after pediatric acute disseminated encephalomyelitis: A nationwide population-based cohort study. Mult Scler Relat Disord. 2019 Nov; 36:101425.
-
Challenges in Differentiating Pediatric Autoimmune CNS Diseases with Similar Clinical and Imaging Phenotypes. AJNR Am J Neuroradiol. 2019 10; 40(10):E60-E61.